Review



a600 phosphorylcholine macklin  (Quidel)


Bioz Verified Symbol Quidel is a verified supplier
Bioz Manufacturer Symbol Quidel manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Quidel a600 phosphorylcholine macklin
    A600 Phosphorylcholine Macklin, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 221 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a600 phosphorylcholine macklin/product/Quidel
    Average 95 stars, based on 221 article reviews
    a600 phosphorylcholine macklin - by Bioz Stars, 2026-05
    95/100 stars

    Images



    Similar Products

    93
    Gold Biotechnology Inc apramycin sulfate
    Apramycin Sulfate, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apramycin sulfate/product/Gold Biotechnology Inc
    Average 93 stars, based on 1 article reviews
    apramycin sulfate - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    93
    Mini-Circuits mini circuits bpf a60
    Mini Circuits Bpf A60, supplied by Mini-Circuits, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mini circuits bpf a60/product/Mini-Circuits
    Average 93 stars, based on 1 article reviews
    mini circuits bpf a60 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    95
    Quidel a600 phosphorylcholine macklin
    A600 Phosphorylcholine Macklin, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a600 phosphorylcholine macklin/product/Quidel
    Average 95 stars, based on 1 article reviews
    a600 phosphorylcholine macklin - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    Quidel 1g f cobra venom factor quidel
    1g F Cobra Venom Factor Quidel, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/1g f cobra venom factor quidel/product/Quidel
    Average 95 stars, based on 1 article reviews
    1g f cobra venom factor quidel - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    Quidel cobra venom factor
    Cobra Venom Factor, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cobra venom factor/product/Quidel
    Average 95 stars, based on 1 article reviews
    cobra venom factor - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    95
    Quidel cobra venom factor cvf
    (A) Percentage of blood cells positive for CFSE-labeled intracellular Lm obtained from peripheral blood of non-pregnant human adults exposed to CFSE-labeled Lm (mean±SEM, n=5 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (B) Percentage of blood cells positive for CFSE-labeled intracellular Lm from isolated non-pregnant human peripheral blood cells exposed to CFSE-labeled Lm (mean±SEM, n=4 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (C) CFUs of intracellular Lm of Lm-infected lysed human neutrophils, PBMCs and platelets (mean±SEM, n=3 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (D) Percentage of human non-pregnant neutrophils positive for intracellular CFSE-labeled Lm after blocking c-Met and/or FcγR (mean±SEM, n=5 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (E) Percentage of human non-pregnant neutrophils positive for intracellular CFSE-labeled Lm after serum treatment via heat inactivation (Hi) and <t>Cobra</t> <t>venom</t> <t>factor</t> <t>(CVF)</t> treatment. Neutrophils in Hank’s Balanced Salt Solution (HBSS) without Lm-infection served as control (mean±SEM, n=3-11 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). *p <0.05, **p <0.01, ***p<0.001, ****p<0.0001.
    Cobra Venom Factor Cvf, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cobra venom factor cvf/product/Quidel
    Average 95 stars, based on 1 article reviews
    cobra venom factor cvf - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    93
    Gold Biotechnology Inc culture a600
    (A) Percentage of blood cells positive for CFSE-labeled intracellular Lm obtained from peripheral blood of non-pregnant human adults exposed to CFSE-labeled Lm (mean±SEM, n=5 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (B) Percentage of blood cells positive for CFSE-labeled intracellular Lm from isolated non-pregnant human peripheral blood cells exposed to CFSE-labeled Lm (mean±SEM, n=4 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (C) CFUs of intracellular Lm of Lm-infected lysed human neutrophils, PBMCs and platelets (mean±SEM, n=3 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (D) Percentage of human non-pregnant neutrophils positive for intracellular CFSE-labeled Lm after blocking c-Met and/or FcγR (mean±SEM, n=5 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (E) Percentage of human non-pregnant neutrophils positive for intracellular CFSE-labeled Lm after serum treatment via heat inactivation (Hi) and <t>Cobra</t> <t>venom</t> <t>factor</t> <t>(CVF)</t> treatment. Neutrophils in Hank’s Balanced Salt Solution (HBSS) without Lm-infection served as control (mean±SEM, n=3-11 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). *p <0.05, **p <0.01, ***p<0.001, ****p<0.0001.
    Culture A600, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/culture a600/product/Gold Biotechnology Inc
    Average 93 stars, based on 1 article reviews
    culture a600 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Percentage of blood cells positive for CFSE-labeled intracellular Lm obtained from peripheral blood of non-pregnant human adults exposed to CFSE-labeled Lm (mean±SEM, n=5 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (B) Percentage of blood cells positive for CFSE-labeled intracellular Lm from isolated non-pregnant human peripheral blood cells exposed to CFSE-labeled Lm (mean±SEM, n=4 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (C) CFUs of intracellular Lm of Lm-infected lysed human neutrophils, PBMCs and platelets (mean±SEM, n=3 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (D) Percentage of human non-pregnant neutrophils positive for intracellular CFSE-labeled Lm after blocking c-Met and/or FcγR (mean±SEM, n=5 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (E) Percentage of human non-pregnant neutrophils positive for intracellular CFSE-labeled Lm after serum treatment via heat inactivation (Hi) and Cobra venom factor (CVF) treatment. Neutrophils in Hank’s Balanced Salt Solution (HBSS) without Lm-infection served as control (mean±SEM, n=3-11 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). *p <0.05, **p <0.01, ***p<0.001, ****p<0.0001.

    Journal: bioRxiv

    Article Title: Neutrophils are critical for placental and fetal infection with the human pathogen Listeria monocytogenes

    doi: 10.64898/2026.03.16.712023

    Figure Lengend Snippet: (A) Percentage of blood cells positive for CFSE-labeled intracellular Lm obtained from peripheral blood of non-pregnant human adults exposed to CFSE-labeled Lm (mean±SEM, n=5 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (B) Percentage of blood cells positive for CFSE-labeled intracellular Lm from isolated non-pregnant human peripheral blood cells exposed to CFSE-labeled Lm (mean±SEM, n=4 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (C) CFUs of intracellular Lm of Lm-infected lysed human neutrophils, PBMCs and platelets (mean±SEM, n=3 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (D) Percentage of human non-pregnant neutrophils positive for intracellular CFSE-labeled Lm after blocking c-Met and/or FcγR (mean±SEM, n=5 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). (E) Percentage of human non-pregnant neutrophils positive for intracellular CFSE-labeled Lm after serum treatment via heat inactivation (Hi) and Cobra venom factor (CVF) treatment. Neutrophils in Hank’s Balanced Salt Solution (HBSS) without Lm-infection served as control (mean±SEM, n=3-11 independent experiments, 1-way ANOVA, Tukey’s multiple comparison). *p <0.05, **p <0.01, ***p<0.001, ****p<0.0001.

    Article Snippet: Prior to Listeria opsonization, human serum was de-complemented using 12 μg of cobra venom factor (CVF) (Quidel, San Diego, USA) per 500 μl of extracted serum and incubated for 1 h at 37 °C ( ).

    Techniques: Labeling, Comparison, Isolation, Infection, Blocking Assay, Combined Bisulfite Restriction Analysis Assay, Control